Data Analytics Center (DAC)
Data Analytics Center (DAC)

Insight

Unlocking the power of Danish Data Analytics Centre

Insight

Unlocking the power of Danish Data Analytics Centre

Learn all about the first Data Analytics Center (DAC) of its kind in Europe opened by the Danish Medicines Agency. We will walk you through how DAC will shape the European regulatory landscape – offering new possibilities for development of medicine (supporting both pre- and post-marketing research activities). 

When

For many years, the Danish healthcare system has systematically collected data and knowledge about the Danish population's diseases and treatment. It has helped researchers and health authorities to better understand, which treatments work and which do not. Users of the Danish healthcare system expect treatment that offers them the best possible outcomes. Therefore, as part of the governmental strategy for personalized medicine in Denmark, the Danish Medicines Agency has established a Data Analytics Centre.




“Denmark has a richness of healthcare data and registries that offer huge potential for the generation of real-world evidence. In medicines regulation this evidence can then support the development and supervision of medicines for the benefits of European patients. DKMA and its Analytics Centre are amongst the European trailblazers in the analysis of healthcare data to support better medicines for patients.” 

Peter Arlett

Head of Data Analytics and Methods at the European Medicines Agency

Peter Arlett - Head of Data Analytics and Methods at the European Medicines Agency

More precise scientific advice 

The Data Analytics Centre is the first of its kind in Europe, supporting regulatory decision-making as well as creating a globally unique research infrastructure also to be used by industry partners. With the Data Analytics Centre, the Danish Medicines Agency is able to offer more precise scientific advice to the pharmaceutical companies in the development of new medicines, including medicines for people with rare diseases or small patient groups.

The key goal

The overall vision for the Data Analytics Centre is, through use of clinical trial and real world data and advanced analytical methods, to increase the accessibility of safe and affective medicines and medical devices. The purpose is to provide both the industry and academia i) better regulatory framework for scientific advises. ii) Give authorities access to applicants’ clinical trial data (CDISC formatted data) in the preapproval process, as well as conditional approvals expands. iii), and in the post-approval part, to give adverse drug reaction supplemented with real world data (RWD).

Comprehensive registers and statistical databases

The centre is highly relevant in Denmark, since the public health service system includes numerous comprehensive registers and statistical databases of extremely high quality – not least Denmark’s national unique personal identifier system (Civil Registration Number or CPR). For 50 years, the Civil Registration Number is issued to all Danish citizens at birth and the citizens are subsequently registered in the public health service system. The Civil Registration Number ensures easy linkage to national registries.

Collaboration with the industry 

The Data Analytics Centre collaborates with the industry in relation to RWD among others. The RWD analysis, which DAC is currently involved in, is in collaboration with academia in Denmark. Furthermore, in collaboration with academia, DAC is currently doing medical device RWD analysis. Besides, DAC is doing pilot projects on both biostatistical analysis (CDISC data) and real time surveillance. More in-depth information about the Data Analytics Centre is available at DAC’s webpage.

Unique opportunities for epidemiological research

The Danish Civil Registration Number system and the numerous statistical databases, registers and journal records offer unique opportunities for epidemiological research of extremely high quality. Given that the aforementioned registers have a long history in Denmark, Danish researchers also have a long tradition of performing register research, public health studies, and epidemiological research, all of which are important prerequisites for the identification and segmenting of relevant target segments and patient populations within personalized medicine.

“One cohort”

When talking more specifically about epidemiology and the Danish registers, it is actually fair to say, that Denmark itself is a cohort. Denmark has gathered more data on its citizens than any other country. Now, Denmark wants to make this array of statistics even more useful. It is easy for Danish scientists to get safe and secure access to all the data in the registries through the websites “Statistics Denmark” and “The Danish Health Data Authority”, which works as single point of access for all the registries. Although Denmark has some of the best and oldest registries in the world, new registries are being development continually. Two of the newest developments are Laboratory values and In-hospital medicines.

With the development of the Data Analytics Centre, the regions and universities obtain secure, confidential, and flexible access to the use of health data. This means more accurate diagnostics and better treatment for the patient. The goal is more use of personalized medicine for the benefit of all patients. 

Data for life - Danish health data

Download fact sheet

Danish health data - unique research & development opportunities in Denmark

Download our fact sheet to get an overview of the R&D opportunities, more knowledge of the Danish life science sector and learn how to get started in Denmark.

Download fact sheet here

get in touch

Want to know more about DAC?

Please contact our dedicated life science experts here:

Copenhagen

  • Sarina Lohmann

    Title: Special Advisor – Maritime and transport – Analysis & Partnerships

    Area: Copenhagen

    Phone: +4533920423

Berlin

Kolding

Silkeborg

Aarhus

Aalborg

Oslo

London

Paris

Munich

New-York

Toronto

Silicon-Valley

Tokyo

Bangalore

Taipei

Shanghai

Singapore